We provide a review of recent research findings which support the involvement of autoimmunity in childhood-onset tic disorders, in particular the presence of antineuronal autoantibodies, D8/17 B lymphocyte overexpression, a marker of chorea associated with streptococcal infection, and possible beneficial effects of immunomodulatory intervention. One of the most controversial areas in this field is the validity of the proposed PANDAS concept. Some researchers have delineated a putatively unique subgroup of patients, from the spectrum of illness encompassing Tourette's syndrome and obsessive-compulsive disorder (OCD), whose tics and obsessive-compulsive symptoms are shown to arise in response to beta-hemolytic streptococcal infections. They designated it by the term pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Herein we additionally present pros and cons concerning the concept of PANDAS. Finally, recommendations for future research directions are given.
Introduction
Gilles de la Tourette's disorder, or Tourette's syndrome (TS), as it is mostly simply referred to, is a neuropsychiatric disorder, characterized by the presence of both motor and vocal tics. A tic is a sudden, rapid, recurrent, nonrhythmic, stereotyped motor movement or vocalization (DSM-IV). Common examples of motor tics include excessive eye blinking, nose twitching, head jerks and tensing the abdomen, whereas throat clearing, coughing and sniffing are the most prevalent vocalizations. Tics typically occur in bouts during the day, 1 whereas the course of tics over a period of months to years often waxes and wanes with regard to their severity. 2 Furthermore, the type of tics in an individual patient is typically changing, with some tics disappearing and new ones appearing in the course of time. With increasing age, however, symptoms tend to decrease in intensity and to show less variation over time regarding both severity and type of tics. 3 The age of onset of tics is mostly between 2 and 15 years with a median of 7.
3 Facial tics are normally the initial symptom. Tics are rather common in childhood, but are most often transient. 4 Males are more commonly affected than females. 5 Movements generally decrease during sleep and may be suppressed for short periods while the patient is awake. 6 Transient tic disorders are estimated to affect at least 5% of children between 7-11 years; population studies estimate prevalence rates for full blown TS between 2.9 and 5.2 cases per 10 000. 5 Transient tic disorder, in which symptoms are required to last less than one year, and chronic motor or chronic vocal tic disorder, in which only one type of tics (either motor or vocal) is involved, are all thought to be etiologically closely related to TS, thus making this DSM-IV based subclassification of tics into separate categories rather artificial.
One interesting feature of TS is its well known association with a wide range of behavioral disorders and psychopathology. 7 Attention deficit hyperactivity disorder (ADHD) is known to affect 50% of referred patients. 8 Obsessive-compulsive symptoms constitute another common cophenomenon of the spectrum of tic disorders. 9 Finally, many children show significant problems with social functioning. 10 Currently, tics are diagnosed on clinical grounds alone. Though tic disorders are no longer regarded as psychogenic, the pathogenesis is poorly understood. Circumstantial evidence from neurochemical and imaging studies stresses the importance of basal ganglia and cortico-striato-thalamocortical circuits. 11 A high degree of heritability is characteristic of tic disorders. Several investigators found that the pattern of vertical transmission within families fitted best to a mode of inheritance of TS involving a single autosomal dominant locus with varying penetrance. No such single gene defect has been found though, despite extensive linkage studies covering most of the genome. 12 
Molecular Psychiatry
Associations for markers within certain chromosomal regions have been reported recently. 13 Our lack of understanding of the pathophysiology of TS and associated phenomena is reflected in the paucity of existing treatment options. They are all purely symptomatic and consist largely of the use of various forms of psychotropic medications, mostly antipsychotic agents.
14 In some individual cases, however, medication does not show any effect on tic severity, whereas in many other cases, the decrease of tic severity achieved by medication is only marginal and far from sufficient. Besides, many patients suffer from troublesome medication side effects, such as sedation and weight gain. This unfavorable situation can be illustrated by the fact that many patients, on long term, choose to live without medication, despite the existence of debilitating tics.
What model of auto-immunity may be involved in the pathogenesis of tic disorders?
Over the past decade a significant amount of research has been conducted on the role of autoimmunity in tic disorders. The proposed model of pathogenesis of tic disorders in this research is analogous to Sydenham's Chorea. 15 In genetically predisposed individuals, tics and associated phenomena are thought to arise as a consequence of the immunological response to infections with Group A beta hemolytic Streptococci (GABHS). Antibodies directed against the streptococci are hypothesized to cross-react with structures of the central nervous system, subsequently leading to damage to these structures, which eventually results in the emergence of tics and associated features. This mechanism of autoimmunity is supposed to be based on molecular mimicry between host and micro-organism.
What data point towards involvement of autoimmunity?
Several clinical observations led to the hypothesis that Sydenham's Chorea might be a model for some types of childhood-onset OCD and tic disorders. First, it had been noted that patients with Sydenham's Chorea shared certain behavioral characteristics with patients with OCD and/or tic disorders, such as emotional lability, marked irritability, but also frank obsessivecompulsive symptoms. 16 Second, a substantial number of children with OCD were reported to show choreiform movements or tics. 17 In addition, in some children with OCD and/or tic disorders, an episodic course and/or abrupt onset of their symptoms seemed to be temporally related to signs of GABHS infections. 15 Following these observations, case studies began to appear in the literature, in which children with OCD and/or tic disorders were described in whom a temporal relationship between symptom onset or exacerbations and GABHS or viral infections seemed apparent. [18] [19] [20] Researchers of the National Institute of Mental Health (NIMH) subsequently proposed criteria to identify a putatively unique subgroup of patients from the spectrum of illness encompassing Tourette's syndrome and obsessive-compulsive disorder (OCD), whose tics and obsessive-compulsive symptoms are shown to arise in response to beta-hemolytic streptococcal infections. They designated it by the term pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), 19 implicitly suggesting that in non-PANDAS cases auto-immunity would not be involved. This concept is not without controversy, however, as will be addressed later in this review. What percentage of children with TS and/or OCD would meet criteria for PANDAS is unknown.
Thus, clinical observations might point to a role for infections preceding the onset or exacerbations of tic or obsessive-compulsive disorders. Other clues for such a relationship stem from laboratory work. Most importantly, autoantibodies reacting with basal ganglia, [21] [22] [23] [24] [25] [26] increased serum levels of streptococcal antibodies [27] [28] [29] as well as the presence of increased binding of an IgM monoclonal antibody to B-lymphocytes, 22 ,30,31 a suggested susceptibility marker for the development of rheumatic fever, have been reported in a majority of patients with OCD and/or tic disorders. Other laboratory hints may come from limited findings on tryptophan metabolism [32] [33] [34] and cytokine profiles. 35 Finally, rather fascinating is the reported success of immunomodulatory interventions (plasmapheresis or intravenous immunoglobulins). 36 All these items will be discussed in the next sections.
Studies demonstrating antineuronal antibodies
A possible indicator of autoimmunity is the presence of autoantibodies directed against components of the central nervous system. So far, several research groups reported the increased presence of these antineuronal antibodies in sera from patients with tic and/or obsessive compulsive disorders, compared to healthy controls. [21] [22] [23] [24] [25] [26] Results, however, have been partially conflicting, and relatively high levels of antineuronal staining have been found in sera from healthy control subjects. Kiessling and coworkers 21 were the first to assess antineuronal antibody status in children with recent onset of movement disorders (Tourette syndrome, motor and/or vocal tics, chorea or choreiform movements), compared with a group of children referred for evaluation of ADHD, behavior disorders, and learning disabilities who did not show signs of a movement disorder. They applied an indirect immunofluorescence technique, with unfixed frozen human caudate nucleus sections as antigenic substrate, using undiluted sera and fluorescein isothiocyanate-labeled secondary antibody directed against human IgG, and found 44% of children with a movement disorder to be strongly positive for antineuronal antibodies. However, also 21% of the control group were strongly positive for antineuronal antibodies. It is unlikely, that the behavioral symptoms of the control group explain the positive antineuronal status in the controls, since two more studies applying the same technique, 16, 22 also found relatively high levels of antineuronal staining in healthy controls, as will be addressed later. Unfortunately, no subsequent two-fold titrations of positive sera were performed in this study, which could have been used to compare titers between patients and controls.
Previously, in 46% of children with Sydenham's chorea, the presence of antibodies reacting with caudate nuclei neurons had been reported. 37 In that study, however, which applied an indirect immunofluorescence technique similar to that in Kiessling's study, contrary to the latter study, none of the healthy control children showed evidence of the presence of antineuronal antibodies. In contrast, two additional studies, which, like Kiessling's work, adopted the method of indirect immunofluorescence on human caudate nucleus sections as described by Husby, 37 found relatively high percentages of positive staining using undiluted sera of healthy controls: Swedo and colleagues 16 reported positive antineuronal antibody titers in 50% and Murphy 22 in 24% of healthy control children. Unfortunately, in these studies, no explicit data are available about the presence of intercurrent infectious illness or autoimmune disorders in the control subjects. In both studies, the percentages of positive antineuronal staining were consistently higher for the patient groups, being 91% for children with Sydenham's chorea in Swedo's study, 16 and 39% for children with tic and/or obsessive compulsive disorder in the report of Murphy. 22 However, again, a comparison of titers between diseased children and controls could not be made, as serum dilutions were not performed.
To summarize, a major problem with previous studies reporting high levels of antineuronal antibodies in patients with tic disorders is the relatively high level of, possibly, non-specific antineuronal staining in normal controls. Therefore, it would have been important, if in both patients and comparison subjects, staining of antibodies to other brain regions than the caudate nucleus would also have been assessed, in order to control for non-specific antineuronal staining. A recent study, also applying indirect immunofluorescence with unfixed frozen caudate sections, using undiluted sera and fluorescein isothiocyanate-labeled anti-human IgG as secondary antibody, was, however, able to detect antineuronal antibody staining in all patients with acute chorea, whereas healthy control subjects showed a complete absence of antineuronal antibodies. 38 Contrary to the previous studies, 16, 21, 22 which used fresh human brains from adult victims of sudden or accidental death, this study used a fresh human brain obtained from an autopsied stillborn cadaver, aged 34 weeks. It would be of interest to apply the same methodology in TS patients.
Measuring levels of antineuronal antibodies more quantitatively, by applying an enzyme-linked immunosorbent assay (ELISA) with human neural tissue from basal ganglia as substrate, TS subjects were shown to have a significant increase in the mean and median ELISA optical density (OD) levels of serum antibodies against putamen, but not against caudate or globus pallidus, when compared with healthy controls. DifferMolecular Psychiatry ences in magnitude of binding were, however, relatively low. 23 These results suggest that the putamen may be a major target site for antineuronal antibodies. Two other studies did not use human neural tissue but an immortal cell line of neural origin as substrate, and also applied ELISA assays. Though using the same methodology, results were conflicting. When described originally, the assay was shown to have the capability to differentiate between normal and Tourette syndrome populations, with a sensitivity and specificity for TS of 79.1 and 61.2%, respectively. 24 A later study, however, did not find differences between children with TS and control children, due to high optical density (OD) values in controls in this study. 25 Finally, a recent study assessed the presence of antineuronal antibodies in subjects with TS and healthy controls with an indirect immunofluorescent assay on unfixed frozen sections from rat brain striatum, and performed serum titrations to an end point by two-fold serial dilutions in order to quantify the levels of immunoreactivity. 26 Again, there was much overlap in levels of immunoreactivity between patients and controls. It is unclear how to interpret this overlap between patients and controls. It raises suspicions of methodological flaws, suggesting rather high levels of non-specific binding, albeit not necessarily, since autoantibodies in healthy subjects have repeatedly been reported. 39 Clearly, according to what criteria an individual's antineuronal antibody assay should be regarded positive has insufficiently been operationalized as yet.
Many questions remain regarding the significance, magnitude and pathophysiological meaning of serum reactivity with neuronal tissue in tic disorders. In paraneoplastic syndromes (PNS) involving the central nervous system, the role of antineuronal antibodies is much more established. First, in this area, the nature of several neuronal antigens has been characterized. Furthermore, end-point titers for positive identification of antibody in general are much higher than is the case in movement disorders. Mostly, titers of Ͼ1:500 will be regarded as positive in the field of PNS, 40 whereas most titers do not exceed 1:8 when movement disorders are concerned. Given these apparently low titers in tic disorders, discriminating differences from controls are fairly small. Correspondingly, confounds of non-specific binding form a great risk when studying antineuronal antibody status in patients with tic disorders, paralleled by relatively high levels of positive reactivity in normal controls reported so far.
To conclude, though several studies suggest the presence of autoantibodies reacting with brain tissue in patients with OCD and/or tic disorders, some of these raise concerns regarding methodology. Moreover, the presence of autoantibodies in the serum of patients with tic disorders does not necessarily point to an autoimmune basis of tic disorders. Autoantibodies are also found when tissue damage is caused by trauma or infection. In other words, autoantibodies can result from, rather than be the cause of tissue damage, as has been reviewed elsewhere. 41 One recent study, however, elegantly suggested a pathogenic role for antineu-ronal antibodies for tic disorders. Through the transfer of antineuronal antibodies of children with TS to the striatum of rats, stereotypic movements and utterances could be induced in these animals. 42 Much remains to be investigated in this area, eg, how autoantibodies present in sera are able to cross the blood-brain barrier, or whether IgG production takes place inside the central nervous system. Simply measuring albumin and total IgG in serum as well as in cerebrospinal fluid would give valuable information about IgG production in the central nervous system and about the functional integrity of the blood-brain barrier. Recently, basic principles of these measurements have been adequately reviewed. 43 Theoretically, in this respect, it would be also of interest, to compare antineuronal antibodies instead of total IgG in both serum and cerobrospinal fluid. Contrary to total IgG, however, we lack accurate quantitative methods of measuring levels of antineuronal antibodies, as has been outlined in the previous sections.
Also, the way in which antibodies against neuronal antigens might induce tics and associated features is unknown. No evidence of antibody-associated inflammation or indications of autoantibody binding to functional cell-surface receptors in central nervous tissue have been collected in the field of tic and related disorders. An animal model as described above, 42 or careful postmortem neuropathological examinations may be fruitful future approaches in this respect.
Association with anti-streptococcal antibody titers
Conflicting results have also been reported on the issue whether increased levels of anti-streptococcal antibodies (antistreptolysin O and antideoxyribunuclease B) are associated with TS. Two recent studies 27, 28 reported large differences between TS cases and normal controls. Muller et al 27 found that 85% of the subjects with TS vs 8% of normal controls had elevated antideoxyribunuclease B levels. The same researchers subsequently showed the presence in TS patients of increased titers against the streptococcal M12 and M19 proteins in TS patients as compared with controls, while antibody titers against M1, M4 and M6 did not differ between the TS and control groups. 29 Also, Cardona et al 28 reported significantly higher mean antistreptolysin titers in children with tics compared to control children, and found a positive correlation between antistreptolysin titers and severity of tic disorder as measured by the Yale Global Tic Severity Scale. Others, however, reported less striking differences in this respect. 23 Despite some inconsistency in these data, overall, a clear association is noticeable between anti-streptococcal antibody titers and tic disorders, further strengthening the relationship between tic disorders and preceding streptococcal infections. Longitudinal data, however, intending to link symptom fluctuations over time to fluctuations of anti-streptococcal antibody titers are highly needed. In addition, though Muller et al 27 did not find increased anti-streptococcal antibody titers in a comparison group of patients with schizophrenia, it remains to be systematically investigated whether elevated anti-streptococcal antibody titers would also be associated with other related neuropsychiatric disorders such as OCD, autism spectrum disorders and anorexia nervosa, or other mental disorders in which mechanisms of autoimmunity sometimes have been suggested, such as affective disorders.
Studies demonstrating elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever
One finding which somehow links tic disorders to rheumatic fever is the greater than usual binding of a D8/17-specific monoclonal antibody to B lymphocytes, reported in patient groups of both disorders. 22 D8/17-specific monoclonal antibody is a mouse monoclonal IgM antibody originally prepared from fusions of spleen cells from mice that had been repeatedly immunized with isolated human B cells obtained from patients with rheumatic fever or rheumatic heart disease. Elevated D8/17 B cell expression was originally investigated as a putative susceptibility marker of rheumatic fever. 44 Two independent research centers reported elevated D8/17 expression on B cells in patients with tic disorders. In these studies, B cells were incubated with the D8/17-specific monoclonal antibody and an anti-mouse IgM specific conjugate, after which D8/17-positive cells were counted by means of fluorescent microscopy. 22, 30 Using the same, somewhat subjective method, elevated D8/17 B cell binding in autism has also been reported. 45 We recently demonstrated higher than usual D8/17 overexpression compared to a control monoclonal antibody in patients with a tic disorder, by means of flow cytometry, an objective rating method in which no operator variability is involved. 31 A significant minority of our patients (39.4%), however, had levels of D8/17 expression within the range of that of our healthy comparison subjects.
The exact meaning and pathogenetic significance of these findings is unknown. The D8/17-specific monoclonal antibody has not only been found to bind to B cell surface structures, but also to the cytoskeletal helical coil/coiled structures myosin and tropomyosin as well as to streptococcal M proteins, possibly suggesting a substrate for structural homologies between host and streptococci. 46 Given the specificity of elevated D8/17 B cell expression for poststreptococcal disorders as reported after extensive studies with this antibody across different autoimmune disease categories, 47 elevated D8/17 B cell expression might point to the involvement of poststreptococcal (auto)immunity in tic disorders. Whether, however, the finding of elevated B cell expression in autistic subjects 45 also implies the involvement of poststreptococcal (auto)immunity in the pathophysiology of autistic disorder, remains to be specifically investigated. In other words, the precise meaning of elevated D8/17 expression remains obscure.
Altered tryptophan metabolism and data on cytokines
One well known and sensitive marker of cellular immune activation is the increased degradation of tryptophan via the kynurenine pathway, leading to elevated plasma levels of kynurenine and subsequent metabolites. 48 Up-regulation of the kynurenine pathway can be induced through increased activity of Indoleamine 2,3-Dioxygenase (IDO), an enzyme active in extra-hepatic tissue including brain, which is sensitive to Interferon-gamma, a major cytokine of cellular immunity. 49 Indeed, in one study, involving only seven patients with a tic disorder, the serum kynurenine level was found to be clearly increased in all seven patients whereas serum tryptophan was normal, 32 thus, possibly reflecting immune activation. In a subsequent larger scale study, involving 72 TS patients and 46 matched controls, again, plasma kynurenine levels were found to be significantly elevated. 33 Interestingly, both studies 32, 33 reported a significant positive correlation in TS patients between levels of kynurenine and neopterin. This finding further supports involvement of (auto)immunity, given the fact that neopterin is a well known marker of cellular immunity, which is, like IDO activity, induced by cytokines. We know of one other independent report of increased plasma kynurenine, 34 further strengthening the significance of this finding.
Also, significantly decreased serum tryptophan levels of TS patients have been reported in two large-scale studies, 50, 51 which would be compatible with increased turnover of tryptophan along the kynurenine pathway. However, cerebrospinal fluid tryptophan levels were found to be normal in a different study. 52 Interestingly, conversion of tryptophan to kynurenine can be triggered by GABHS, as has been recently shown in vitro. 53 In that study, streptococcal erythrogenic toxins, exposed to a peripheral blood mononuclear cell culture were demonstrated to stimulate tryptophan degradation to kynurenine.
An alternative explanation for increased plasma kynurenine, other than through immune based IDO activation, would be activation of cortisol-inducible tryptophan dioxygenase (TDO), possibly reflecting heightened stress response. 54 However, contrary to neopterin, cortisol was not found to show a correlation with kynurenine.
33 Surprisingly, the studies reporting on elevated plasma kynurenine [32] [33] [34] did not yield elevated levels of quinolinic acid and kynurenic acid, two further metabolites along the kynurenine pathway. 55 Increased levels of quinolinic acid are known to be correlated with different immune-based neurologic conditions, among others the AIDS dementia complex. 56, 57 When present in higher than usual levels in brain tissue, quinolinic acid is toxic to neurons, leading to a loss of neuronal cell density. Cerebrospinal fluid levels of quinolinic acid are closely associated with severity of neurologic damage in inflammatory brain disease. 56, 58 Therefore, it would be of interest, to study Molecular Psychiatry kynurenine pathway metabolites in cerebrospinal fluid of TS patients. Precisely how an altered metabolism of tryptophan might contribute to the pathogenesis of tics is not clear. It can be an epiphenomenon, merely reflecting a state of immune activation. Another possibility is a direct toxic effect of kynurenine or one of its metabolites in the basal ganglia. Some authors found that kynurenine increases tic-like behaviour in an animal model of TS: in mice, head-shakes which had been induced by the 5-hydroxytryptamine receptor agonist dimethoxy-iodophenyl-aminopropane were potentiated by administration of kynurenine. 59 A third possibility would be that reduced levels of tryptophan could lead to reduced synthesis of serotonin causing perturbations in serotonergic transmission. The last two possibilities are not mutually exclusive.
Clearly, however, more data are needed concerning altered tryptophan metabolism in patients with tic and related disorders to allow for more definite conclusions. Unfortunately, studies which investigated cytokines in pediatric neuropsychiatric disease are scarce. Patients with OCD were reported in one study to show a relative preponderance in cerebrospinal fluid of type 1 cytokines, notably interleukine-2, suggesting the involvement of cell-mediated immunity. 35 This could be consistent with a role for streptococcal infection, through the involvement of streptococcal erythrogenic toxins, which can act as superantigens and are known to induce type 1 cytokines. 53, 60 Cytokines are proteins made by cells that affect the behavior of other cells. One function of cytokines is to shape the type of adaptive immunity in response to a pathogen, by determining the fate of naive CD4 T cells. Proliferating CD4 T cells can differentiate into type 1 CD4 T cells (Th1 cells) or type 2 CD4 T cells (Th2 cells), which mainly depends on the type of cytokines produced in response to pathogens by cells of the innate non-adaptive immune system. Th1 cells are involved in activating macrophages, resulting in cellmediated immunity whereas type Th2 cells have their main function in stimulating B cells to become antibody producing plasma cells.
Given the known IDO induction capacities of interferon gamma, it would be of interest to study cytokine profiles in patients with tic disorders. At present, no such studies are available.
Application of immunomodulatory interventions in tic disorders
One attractive consequence of the accumulating evidence supporting the involvement of autoimmunity in the pathophysiology of tic disorders is the development of new treatment options, targeting on the supposed pathophysiology instead of being purely symptomatic. The existing literature concerning immunomodulatory therapy for Tourette's and related disorders is still surprisingly scarce, and is confined to a handful of case studies and one placebo controlled study.
A small number of case studies reported improvement in tic severity after immunosuppression with corticosteroids. [61] [62] [63] Other case studies in the literature report dramatic symptom improvement in children fulfilling criteria of PANDAS with either plasmapheresis, [18] [19] [20] or intravenous immunoglobulin (IVIG). 20, 64, 65 In some of these case studies, after successful plasmapheresis, attempts have been made to prevent new GABHS infections with penicillin prophylaxis. 20 We know of only one placebo controlled study on the efficacy of immunomodulatory therapy in patients with TS/OCD. 36 In that study, a total number of 30 children meeting PANDAS criteria, were randomly assigned to either plasmapheresis, IVIG or a placebo condition (saline solution given in the same manner as IVIG), and subsequently each patient was given a regimen of penicillin prophylaxis. Symptom severity was rated at baseline and at 1 month and 12 months after treatment by use of standard assessment scales for OCD, tics, anxiety, depression and global functioning. At 1 month after treatment the IVIG/placebo masking was broken. At 1 month, the IVIG and plasma-exchange groups showed striking improvements in severity of OCD symptoms, anxiety and overall functioning. Tic symptoms were significantly improved by plasma exchange only. The children in the placebo condition did not show any amelioration. Interestingly, these improvements were maintained at 1 year after treatment for both plasmapheresis and IVIG. Though these results are intriguing, the study of Perlmutter and colleagues has some serious drawbacks. At baseline, tic severity in the plasma-exchange group was significantly higher than in the IVIG and sham IVIG groups, which makes it hard to evaluate the effect of IVIG on tic severity. Blinding of the treatment groups was already broken at 1 month after treatment. In fact the study lacks an acceptable sustained placebo condition. Another serious drawback is the limited number of symptom rating moments, both before and after treatment. As a consequence, we lack knowledge of the way of natural symptom fluctuation in the groups vs the possible effect of intervention.
Perlmutter and colleagues did not use laboratory measures in their assessment after treatment, so from Perlmutter's data, we cannot gain insight in possible treatment mechanisms. More specifically, baseline and post treatment levels of antineuronal antibodies and percentages of D8/17 positive B-lymphocytes would have been of interest. Two more problems are the small number of patients in each treatment arm and the confounding role of the use of penicillin.
Certainly, further, larger scale studies on the effectiveness of immune-based therapies in well characterized patients with tic disorders would be of great interest.
How valuable is the PANDAS concept?
Many problems are associated with the concept of PANDAS, both methodologically and fundamentally. The diagnostic criteria for PANDAS are not easy to apply. Especially, it is hard to demonstrate a temporal association between GABHS infection and symptom onset and exacerbations. In fact, as far as such an association in tic or obsessive compulsive disorder exists, no knowledge is available of the nature of this association. Interestingly, in Sydenham's chorea, a latent period between onset of symptoms and the preceding GABHS infection as long as 6 months is not uncommon. 66 Streptococcal infections are fairly common in children in general, 67 as are remissions and exacerbations in children with tic disorders. 68 Another criterion for PANDAS, the presence of an episodic course of symptom severity with explosive exacerbations and remissions has insufficiently been operationalized. An episodic course of symptoms is characteristic of pediatric tic and OCD symptoms in general, but it is hard to say when exacerbations can exactly be called explosive.
The significance and validity of PANDAS remains to be established, since we lack direct comparisons between TS subjects who do and TS subjects who do not meet criteria for PANDAS. Comparative studies in this respect should include comprehensive clinical and serological features in relation to response to treatment. Besides, much of the evidence supporting a role for autoimmunity in tic disorders in general has been based on unselected subjects. Findings in unselected cases have been similar in magnitude as in cases fulfilling criteria for PANDAS. All of the findings supporting autoimmunity as outlined in the previous sections are equally valid for unselected TS patients. These include the D8/17 B cell overexpression 22, 31 and levels of increased antineuronal autoantibodies, 24 both of which are the most robust indicators of a role for autoimmunity. There is, however, one major exception: researchers at the NIMH recently conducted an open trial of plasma exchange in five patients with non-PANDAS OCD, after which none showed significant improvement. 69 To fully investigate the usefulness of the proposed PANDAS concept, more studies comparing TS subjects fulfilling the PANDAS criteria with non-PANDAS subjects will have to be performed. At present it suffices to state that PANDAS probably simply represents those patients who feature the most obvious relationship with GABHS infections.
Apart from the point whether or not PANDAS is a useful concept, one may question, what type of symptoms should be included in the spectrum of tic and related disorders. The PANDAS criteria simply require the presence of OCD and/or a tic disorder as the first criterion, 70 thus lumping together two types of disorders, which are generally regarded distinct in phenomenology and presumed etiology. 71 Only a subgroup of pediatric OCD may be etiologically related to tic disorders, characterized by a family history of tics, a more familial subtype in general, male preponderance, association with disruptive behavior and developmental disorders, and a less striking association with mood disorders. 72 The predominant phenomenology of obsessions/compulsions also differs between ticrelated and non-tic-related OCD. Presence of hoarding/symmetry and sexual and aggressive symptoms predominates in the former, whereas in non-ticrelated OCD symptoms of contamination/checking prevail. 73 In tic-related OCD, compulsions do not generally appear to be anxiety-driven, but rather could be phenomenologically regarded as complex tic behaviors. It is well known that so-called mental tics form a part of tic symptomatology, and it is our clinical impression that in many cases certain obsessions and compulsions could be better conceptualized as mental and complex tics, respectively. Thus, it may well be that the presence of tics, or, more general, a movement disorder, in contrast to anxiety-driven obsessions and compulsions, forms the distinctive feature of those neuropsychiatric disorders which may be related to autoimmunity. Our preliminary, unpublished data on D8/17 B cell overexpression in OCD suggest, that only tic-related OCD shows increased expression of this marker of rheumatic fever.
In conclusion, the concept of PANDAS is ill defined, is not supported by unique immunologic findings which have not been reported in unselected patients, and is phenomenologically unsound. It would be better to define homogeneous subgroups by means of both clinical and laboratory characteristics. Presence of antineuronal antibodies, or levels of D8/17 B cell overexpression might be two candidate approaches.
Conclusions and future directions
A growing body of research data indicates the involvement of autoimmunity in the pathogenesis of at least a subgroup of patients with tic and related disorders. The most fascinating data include the work on antineuronal autoantibodies, [21] [22] [23] [24] [25] [26] especially regarding their potential in generating disease in an animal model, 42 the association with B lymphocyte D8/17 expression, 22, 30, 31 and the promising data concerning immunomodulatory approaches 36 in a disorder which is otherwise hard to manage. Given the economic costs, and the invasiveness of these interventions, future research should focus on the identification of patients in whom autoimmunity may be involved, and who may subsequently profit from immunomodulatory treatments.
Much more work remains to be done in this field, however. The characterization of the antigen recognized by the D8/17-specific monoclonal antibody as well as the characterization of the brain antigenic structures recognized by the antineuronal antibodies awaits further study. Western blot analyses which can identify antibodies against specific antigenic structures have been inconclusive so far. 23 Post-mortem studies in search of inflammatory alterations warrant further attention.
Furthermore, large-scale longitudinal data are needed to investigate the role of infections with regard to symptom fluctuation. Many areas remain neglected. Just a few studies examined the Human Leukocyte Antigen (HLA) system. [74] [75] [76] Since many human autoimmune diseases show HLA-linked disease associations, studying HLA-associations would be of great Molecular Psychiatry interest in homogeneous, immune-based subgroups of tic disorders. Also, we lack imaging studies aimed at visualizing possible blood-brain barrier ruptures. Of special interest in this regard is the report by Kienzle and coworkers 77 demonstrating focal blood-brain barrier disruption confined to the head of the caudate nucleus in two patients with Sydenham's chorea during the active phase of the disease by magnetic resonance imaging after intravenous administration of gadopentetate dimeglumine. Interestingly, when repeating the procedure in these patients after symptoms had greatly diminished, leakage of contrast was absent.
Ultimately, unraveling the genetic background of tic and related disorders will hopefully lead to a better understanding of environmental factors and more targeted treatment.
